NCT07174297View on ClinicalTrials.gov

Acotiamide vs Itopride in Postprandial Distress Syndrome

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

October 30, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

April 30, 2027

Conditions
Postprandial Distress Syndrome
Interventions
DRUG

Acotiamide

Both these drugs are used for the management of PDS type of FD

Sponsors

Lead Sponsor

Getz Pharma
All Listed Sponsors
collaborator

Rawalpindi Medical College, Pakistan

OTHER

lead

Getz Pharma

INDUSTRY

NCT07174297 - Acotiamide vs Itopride in Postprandial Distress Syndrome | Biotech Hunter | Biotech Hunter